Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.11 trillion and total revenue of $110 billion.
Market Cap
1.11T
Revenue
110B
Profits
-41.27B
PE Ratio
n/a
Profit Margin
-37.51%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.12B | 3.13% | 1,362,202 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 63.97B | 1.58% | 974,643 | 14.92B |
| 3 | ARGX | argenx SE | 52.69B | 3.58% | 228,927 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.54B | 3.78% | 1,081,375 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 33.10B | -0.19% | 2,608,582 | - |
| 6 | RPRX | Royalty Pharma plc | 31.68B | 0.09% | 4,588,439 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 31.12B | 0.33% | 99,471 | 5.70B |
| 8 | INSM | Insmed Incorporated | 22.74B | 1.02% | 1,849,170 | 819.56M |
| 9 | BNTX | BioNTech SE | 22.66B | 1.29% | 860,971 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.24B | 2.89% | 4,244,384 | 8.26M |
| 11 | MRNA | Moderna, Inc. | 20.47B | 5.16% | 6,701,938 | 2.23B |
| 12 | INCY | Incyte Corporation | 20.23B | 3.33% | 1,780,001 | 5.36B |
| 13 | GMAB | Genmab A/S | 15.12B | 3.56% | 1,240,289 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.06B | 3.95% | 1,296,605 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 13.59B | 0.95% | 467,681 | 998.25M |
| 16 | EXEL | Exelixis, Inc. | 13.19B | 1.72% | 2,409,501 | 2.38B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.19B | 2.83% | 1,968,800 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.42B | 1.77% | 1,241,122 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 11.91B | -0.86% | 557,778 | 708.24M |
| 20 | SMMT | Summit Therapeutics Inc. | 11.52B | -1.53% | 4,789,950 | - |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.36B | 0.96% | 219,096 | 1.13B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.91B | 3.31% | 2,077,384 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.59B | 3.60% | 1,130,252 | 622.01M |
| 24 | CYTK | Cytokinetics, Incorporated | 9.81B | 2.23% | 1,312,415 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 9.07B | 1.98% | 264,886 | 417.30M |
| 26 | HALO | Halozyme Therapeutics, Inc. | 8.49B | 2.55% | 2,232,343 | 1.51B |
| 27 | TECH | Bio-Techne Corporation | 8.33B | 4.58% | 3,541,876 | 1.21B |
| 28 | CORT | Corcept Therapeutics Incorporated | 8.04B | 3.08% | 909,792 | 769.10M |
| 29 | ABVX | ABIVAX Société Anonyme | 7.78B | 16.39% | 5,261,316 | 5.67M |
| 30 | IBRX | ImmunityBio, Inc. | 7.64B | 1.53% | 9,605,521 | 140.98M |
| 31 | NUVL | Nuvalent, Inc. | 7.43B | 4.26% | 937,856 | - |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 7.38B | -5.08% | 1,084,488 | 7.46M |
| 33 | PCVX | Vaxcyte, Inc. | 7.04B | 3.90% | 1,232,786 | - |
| 34 | SYRE | Spyre Therapeutics, Inc. | 6.82B | 6.75% | 871,449 | - |
| 35 | APGE | Apogee Therapeutics, Inc. | 6.81B | 7.97% | 1,471,227 | - |
| 36 | IMVT | Immunovant, Inc. | 6.71B | 4.88% | 1,343,004 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.61B | 7.74% | 658,834 | 74.06M |
| 38 | LEGN | Legend Biotech Corporation | 6.35B | -4.95% | 3,272,168 | 1.14B |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.16B | -0.13% | 1,972,461 | 15.00M |
| 40 | KYMR | Kymera Therapeutics, Inc. | 6.14B | 1.95% | 752,694 | 51.48M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.00B | 3.42% | 392,964 | 217.17M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.86B | 2.85% | 1,098,008 | 827.11M |
| 43 | TGTX | TG Therapeutics, Inc. | 5.75B | 1.12% | 1,994,107 | 700.35M |
| 44 | BLTE | Belite Bio, Inc | 5.68B | 5.27% | 312,655 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.64B | 0.71% | 697,667 | 569.61M |
| 46 | COGT | Cogent Biosciences, Inc. | 5.60B | 1.64% | 1,599,980 | - |
| 47 | CRSP | CRISPR Therapeutics AG | 5.49B | 9.35% | 3,299,496 | 4.10M |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.43B | 1.55% | 856,201 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.12B | -0.88% | 1,365,367 | 7.50M |
| 50 | CGON | CG Oncology, Inc. | 4.95B | 3.07% | 653,905 | 5.07M |
| 51 | CAI | Caris Life Sciences, Inc. | 4.88B | 11.63% | 3,197,605 | 907.29M |
| 52 | LGND | Ligand Pharmaceuticals Incorporated | 4.73B | 0.68% | 230,386 | 274.48M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.60B | -1.00% | 901,584 | 1.34M |
| 54 | CELC | Celcuity Inc. | 4.51B | 3.96% | 3,960,187 | - |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.29B | 2.17% | 1,609,913 | 536.20M |
| 56 | MANE | Veradermics, Incorporated | 4.23B | 4.64% | 439,779 | - |
| 57 | ERAS | Erasca, Inc. | 4.13B | 0.68% | 7,958,314 | - |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.01B | 2.82% | 909,404 | - |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.03% | 1,025,333 | 596.96M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.82B | 1.74% | 1,457,526 | 22.57M |
| 61 | ORKA | Oruka Therapeutics, Inc. | 3.76B | 8.88% | 1,477,697 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | 1.35% | 1,122,668 | 1.10B |
| 63 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.65B | 4.65% | 1,090,541 | 18.07M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.46B | 1.53% | 1,723,735 | - |
| 65 | BEAM | Beam Therapeutics Inc. | 3.27B | 11.13% | 4,392,572 | 164.01M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.20B | 3.17% | 1,247,586 | 56.99M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.20B | 2.44% | 1,833,121 | - |
| 68 | RLAY | Relay Therapeutics, Inc. | 3.17B | -4.97% | 5,090,856 | 10.68M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.12B | 8.78% | 460,497 | 803.79M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.11B | 3.48% | 507,337 | 236.00M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.04B | 2.33% | 1,446,144 | - |
| 72 | GPCR | Structure Therapeutics Inc. | 2.78B | 4.16% | 643,061 | - |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.75B | 2.81% | 1,064,750 | 415.62M |
| 74 | KLRA | Kailera Therapeutics, Inc. | 2.72B | -6.21% | 438,228 | - |
| 75 | IRON | Disc Medicine, Inc. | 2.72B | 1.08% | 469,176 | - |
| 76 | DFTX | Definium Therapeutics, Inc. | 2.68B | 4.24% | 2,563,972 | - |
| 77 | ALMS | Alumis Inc. | 2.60B | 1.54% | 729,523 | 8.40M |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.60B | 2.69% | 362,283 | 535.08M |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.57B | 2.89% | 687,710 | 225.27M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.40B | 6.75% | 2,981,438 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 0.54% | 592,043 | 865.00K |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | 4.02% | 1,412,117 | 670.00M |
| 83 | IMNM | Immunome, Inc. | 2.23B | -0.66% | 878,435 | 4.02M |
| 84 | PHVS | Pharvaris N.V. | 2.20B | 4.94% | 361,807 | - |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.16B | -1.50% | 1,098,929 | - |
| 86 | KOD | Kodiak Sciences Inc. | 2.13B | 0.86% | 749,581 | - |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 4.47% | 2,628,757 | 298.30M |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.07B | -0.04% | 2,699,470 | - |
| 89 | NTLA | Intellia Therapeutics, Inc. | 2.06B | 13.29% | 8,966,181 | 66.09M |
| 90 | RXRX | Recursion Pharmaceuticals, Inc. | 2.02B | 9.51% | 38,913,945 | 66.41M |
| 91 | NKTR | Nektar Therapeutics | 2.00B | 0.14% | 1,134,261 | 55.63M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 1.98B | 3.57% | 877,514 | - |
| 93 | IOVA | Iovance Biotherapeutics, Inc. | 1.96B | 15.57% | 21,727,775 | 285.61M |
| 94 | ZLAB | Zai Lab Limited | 1.95B | 0.99% | 666,205 | 453.28M |
| 95 | ABCL | AbCellera Biologics Inc. | 1.94B | 11.36% | 11,445,202 | 79.21M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 1.93B | 5.39% | 1,824,230 | 52.04M |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | 2.68% | 639,409 | 899.11M |
| 98 | GENB | Generate Biomedicines, Inc. | 1.88B | 13.87% | 2,509,995 | 30.30M |
| 99 | STOK | Stoke Therapeutics, Inc. | 1.88B | 2.24% | 320,720 | 32.08M |
| 100 | MESO | Mesoblast Limited | 1.87B | 2.82% | 144,053 | 65.38M |
| 101 | ADMA | ADMA Biologics, Inc. | 1.85B | 2.84% | 2,202,821 | 509.86M |
| 102 | LKFT | Lakefront Biotherapeutics NV | 1.84B | 2.18% | 148,928 | 1.20B |
| 103 | NBTX | Nanobiotix S.A. | 1.84B | 4.55% | 19,824 | 38.27M |
| 104 | ZYME | Zymeworks Inc. | 1.83B | 3.08% | 467,167 | 81.26M |
| 105 | VRDN | Viridian Therapeutics, Inc. | 1.83B | 1.35% | 1,194,836 | 70.92M |
| 106 | VCEL | Vericel Corporation | 1.82B | 2.73% | 707,277 | 292.09M |
| 107 | NUVB | Nuvation Bio Inc. | 1.80B | 9.53% | 6,718,232 | 143.05M |
| 108 | RAPP | Rapport Therapeutics, Inc. | 1.79B | 1.32% | 203,974 | 20.00M |
| 109 | QURE | uniQure N.V. | 1.77B | -6.33% | 2,619,213 | 18.09M |
| 110 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | 2.59% | 2,071,454 | 2.18B |
| 111 | BHVN | Biohaven Ltd. | 1.72B | 5.46% | 3,124,415 | - |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 4.01% | 648,157 | 66.05M |
| 113 | SION | Sionna Therapeutics, Inc. | 1.71B | 2.94% | 328,496 | - |
| 114 | TSHA | Taysha Gene Therapies, Inc. | 1.69B | 6.13% | 2,600,928 | 7.47M |
| 115 | AAPG | Ascentage Pharma Group International | 1.69B | 2.29% | 4,850 | 82.08M |
| 116 | SLS | SELLAS Life Sciences Group, Inc. | 1.68B | 10.38% | 8,367,778 | - |
| 117 | NVAX | Novavax, Inc. | 1.68B | -0.10% | 4,962,858 | 596.34M |
| 118 | ATAI | AtaiBeckley Inc. | 1.65B | -0.66% | 4,553,506 | 3.49M |
| 119 | PVLA | Palvella Therapeutics, Inc. | 1.65B | -0.52% | 207,650 | - |
| 120 | INVA | Innoviva, Inc. | 1.64B | 2.12% | 720,244 | 420.69M |
| 121 | FTRE | Fortrea Holdings Inc. | 1.63B | 10.36% | 2,990,444 | 2.71B |
| 122 | CAPR | Capricor Therapeutics, Inc. | 1.62B | 1.12% | 584,153 | 11.13M |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.62B | -5.26% | 1,294,209 | - |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.60B | -1.74% | 7,010,461 | 217.17M |
| 125 | GHRS | GH Research PLC | 1.60B | -4.83% | 282,683 | - |
| 126 | NRIX | Nurix Therapeutics, Inc. | 1.58B | -1.29% | 1,578,348 | 71.78M |
| 127 | VIR | Vir Biotechnology, Inc. | 1.54B | 4.33% | 1,444,551 | 65.50M |
| 128 | AVBP | ArriVent BioPharma, Inc. | 1.54B | 11.11% | 744,729 | - |
| 129 | ANAB | AnaptysBio, Inc. | 1.50B | 0.84% | 323,965 | 232.39M |
| 130 | MBX | MBX Biosciences, Inc. | 1.47B | 2.86% | 543,917 | - |
| 131 | GLUE | Monte Rosa Therapeutics, Inc. | 1.47B | -1.31% | 729,623 | 42.95M |
| 132 | IMCR | Immunocore Holdings plc | 1.46B | 0.38% | 300,741 | 412.81M |
| 133 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | - | 826,064 | 114.48M |
| 134 | SEPN | Septerna, Inc. | 1.41B | 2.68% | 290,672 | 72.26M |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.41B | 2.17% | 455,859 | 20.00M |
| 136 | MLTX | MoonLake Immunotherapeutics | 1.38B | 2.46% | 439,729 | - |
| 137 | PGEN | Precigen, Inc. | 1.38B | 1.31% | 4,089,889 | 31.60M |
| 138 | DMRA | Damora Therapeutics, Inc. | 1.37B | -0.09% | 458,616 | - |
| 139 | IMTX | Immatics N.V. | 1.37B | -0.15% | 456,058 | 43.00M |
| 140 | MPLT | MapLight Therapeutics, Inc. | 1.36B | 6.21% | 397,280 | - |
| 141 | URGN | UroGen Pharma Ltd. | 1.34B | 3.76% | 329,752 | 140.49M |
| 142 | SVRA | Savara Inc. | 1.34B | 0.95% | 1,026,853 | - |
| 143 | BCAX | Bicara Therapeutics Inc. | 1.34B | 2.05% | 221,148 | - |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.34B | -4.17% | 388,715 | 1.30M |
| 145 | ARDX | Ardelyx, Inc. | 1.33B | -0.37% | 2,324,192 | 427.68M |
| 146 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.29B | 3.10% | 4,447,250 | 204.73M |
| 147 | WVE | Wave Life Sciences Ltd. | 1.17B | 5.73% | 3,420,555 | 71.80M |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.16B | 5.63% | 508,432 | 10.00M |
| 149 | ABSI | Absci Corporation | 1.14B | 23.57% | 8,658,146 | 1.84M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.13B | 2.23% | 180,255 | - |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | -3.13% | 105,729 | - |
| 152 | AKTS | Aktis Oncology, Inc. | 1.10B | 2.68% | 151,653 | 8.28M |
| 153 | MNKD | MannKind Corporation | 1.09B | 4.76% | 3,516,760 | 360.78M |
| 154 | DBVT | DBV Technologies S.A. | 1.03B | -0.68% | 173,347 | 5.74M |
| 155 | EYPT | EyePoint, Inc. | 1.03B | -0.65% | 728,725 | 7.61M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 985.54M | 1.03% | 806,977 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 948.14M | 3.77% | 122,210 | - |
| 158 | OLMA | Olema Pharmaceuticals, Inc. | 932.87M | 1.62% | 857,414 | - |
| 159 | DRTS | Alpha Tau Medical Ltd. | 927.91M | -2.74% | 1,476,976 | - |
| 160 | SPRY | ARS Pharmaceuticals, Inc. | 900.68M | 3.66% | 817,042 | 98.99M |
| 161 | ANNX | Annexon, Inc. | 892.94M | 1.11% | 3,229,357 | - |
| 162 | XNCR | Xencor, Inc. | 890.44M | 5.17% | 941,660 | 97.36M |
| 163 | PHAR | Pharming Group N.V. | 890.00M | 0.41% | 11,663 | 369.49M |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 886.84M | -5.13% | 984,147 | - |
| 165 | MGTX | MeiraGTx Holdings plc | 886.27M | 1.92% | 572,423 | 79.76M |
| 166 | IVA | Inventiva S.A. | 881.34M | 4.70% | 1,919,228 | 7.94M |
| 167 | JBIO | Jade Biosciences, Inc. | 875.64M | 0.85% | 3,500,508 | - |
| 168 | ABUS | Arbutus Biopharma Corporation | 859.29M | - | 599,133 | 191.45M |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 843.97M | 2.70% | 1,756,835 | 69.64M |
| 170 | TBPH | Theravance Biopharma, Inc. | 843.92M | 2.83% | 409,756 | 109.78M |
| 171 | JANX | Janux Therapeutics, Inc. | 839.45M | 1.29% | 620,981 | 13.73M |
| 172 | ORIC | ORIC Pharmaceuticals, Inc. | 830.21M | 2.30% | 1,068,335 | - |
| 173 | LBRX | LB Pharmaceuticals Inc | 829.90M | 3.54% | 167,861 | - |
| 174 | SANA | Sana Biotechnology, Inc. | 823.74M | -5.13% | 3,891,032 | - |
| 175 | REPL | Replimune Group, Inc. | 814.99M | -1.10% | 7,088,802 | - |
| 176 | ODTX | Odyssey Therapeutics, Inc. | 801.96M | 1.86% | 200,529 | 2.98M |
| 177 | PHAT | Phathom Pharmaceuticals, Inc. | 783.18M | -2.28% | 1,038,044 | 204.89M |
| 178 | KURA | Kura Oncology, Inc. | 778.55M | 1.33% | 2,094,020 | 71.64M |
| 179 | GERN | Geron Corporation | 776.24M | 4.31% | 9,288,268 | 196.12M |
| 180 | VOR | Vor Biopharma Inc. | 775.94M | 6.55% | 607,013 | - |
| 181 | AURA | Aura Biosciences, Inc. | 750.04M | -1.16% | 492,043 | - |
| 182 | DRUG | Bright Minds Biosciences Inc. | 749.19M | 0.11% | 824,960 | - |
| 183 | EVMN | Evommune, Inc. | 745.22M | 4.87% | 417,029 | 10.00M |
| 184 | OMER | Omeros Corporation | 741.85M | 0.89% | 1,407,036 | 9.89M |
| 185 | AVTX | Avalo Therapeutics, Inc. | 715.42M | -0.95% | 1,343,496 | 59.00K |
| 186 | OCS | Oculis Holding AG | 714.39M | -9.97% | 1,291,071 | 1.40M |
| 187 | SLDB | Solid Biosciences Inc. | 712.78M | 5.69% | 1,009,088 | - |
| 188 | ALLO | Allogene Therapeutics, Inc. | 704.12M | 2.00% | 6,616,229 | 22.00K |
| 189 | ANRO | Alto Neuroscience, Inc. | 702.11M | 6.26% | 366,838 | - |
| 190 | CTMX | CytomX Therapeutics, Inc. | 692.30M | -1.24% | 2,944,739 | 35.54M |
| 191 | CADL | Candel Therapeutics, Inc. | 679.22M | 5.34% | 2,766,930 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 672.04M | 3.07% | 388,359 | - |
| 193 | CRMD | CorMedix Inc. | 669.98M | 3.77% | 1,446,830 | 400.05M |
| 194 | RLMD | Relmada Therapeutics, Inc. | 661.86M | -0.32% | 817,109 | - |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 660.32M | 1.92% | 949,191 | 122.29M |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 659.28M | 2.49% | 93,748 | - |
| 197 | ACRS | Aclaris Therapeutics, Inc. | 657.82M | 6.56% | 1,065,953 | 8.37M |
| 198 | TENX | Tenax Therapeutics, Inc. | 652.96M | 2.97% | 883,552 | - |
| 199 | SGP | SpyGlass Pharma, Inc. | 643.13M | 3.66% | 58,500 | - |
| 200 | TRAX | First Tracks Biotherapeutics, Inc. | 635.04M | 18.80% | 517,255 | - |
| 201 | PRME | Prime Medicine, Inc. | 626.74M | 10.51% | 3,844,229 | 4.03M |
| 202 | CBIO | Crescent Biopharma, Inc. | 613.08M | 2.61% | 157,832 | 11.88M |
| 203 | DNA | Ginkgo Bioworks Holdings, Inc. | 591.19M | 3.67% | 4,186,984 | 151.40M |
| 204 | IMMX | Immix Biopharma, Inc. | 587.64M | -0.24% | 1,224,034 | - |
| 205 | AGMB | AgomAb Therapeutics NV | 585.56M | -0.92% | 125,434 | - |
| 206 | CABA | Cabaletta Bio, Inc. | 572.32M | -1.96% | 3,824,058 | - |
| 207 | ALT | Altimmune, Inc. | 567.86M | 1.74% | 2,818,662 | 36.00K |
| 208 | GYRE | Gyre Therapeutics, Inc. | 565.59M | 8.79% | 129,019 | 117.05M |
| 209 | MDXG | MiMedx Group, Inc. | 563.01M | 4.71% | 1,327,746 | 389.42M |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 559.69M | -0.17% | 230,310 | 299.77M |
| 211 | PROK | ProKidney Corp. | 558.81M | 6.94% | 719,140 | 889.00K |
| 212 | TECX | Tectonic Therapeutic, Inc. | 549.66M | 2.50% | 56,979 | - |
| 213 | ACHV | Achieve Life Sciences, Inc. | 543.07M | 7.52% | 1,290,536 | - |
| 214 | VALN | Valneva SE | 538.38M | 1.61% | 20,628 | 180.25M |
| 215 | INDP | Indaptus Therapeutics, Inc. | 537.90M | 114.93% | 44,228,710 | - |
| 216 | XOMA | XOMA Royalty Corporation | 531.74M | 1.68% | 133,431 | 48.56M |
| 217 | EIKN | Eikon Therapeutics, Inc. | 529.48M | 3.71% | 283,207 | - |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 523.29M | 5.04% | 1,051,796 | 88.24M |
| 219 | CLYM | Climb Bio, Inc. | 521.15M | 4.50% | 1,119,097 | - |
| 220 | ARVN | Arvinas, Inc. | 499.39M | 0.52% | 428,628 | 89.40M |
| 221 | PRTA | Prothena Corporation plc | 484.27M | 3.70% | 504,872 | 57.94M |
| 222 | KYTX | Kyverna Therapeutics, Inc. | 481.22M | 1.66% | 590,401 | - |
| 223 | ASMB | Assembly Biosciences, Inc. | 477.79M | -1.87% | 215,193 | 71.10M |
| 224 | STRO | Sutro Biopharma, Inc. | 475.24M | 5.52% | 250,103 | 99.61M |
| 225 | RZLT | Rezolute, Inc. | 471.15M | -1.53% | 1,992,521 | - |
| 226 | OCGN | Ocugen, Inc. | 463.77M | 5.38% | 3,529,345 | 4.47M |
| 227 | OVID | Ovid Therapeutics Inc. | 462.87M | 3.77% | 1,276,297 | 7.12M |
| 228 | CTNM | Contineum Therapeutics, Inc. | 459.85M | -1.44% | 245,758 | - |
| 229 | CCCC | C4 Therapeutics, Inc. | 459.45M | 5.30% | 1,548,645 | 34.86M |
| 230 | EDIT | Editas Medicine, Inc. | 458.85M | 7.55% | 2,512,167 | 38.69M |
| 231 | AUTL | Autolus Therapeutics plc | 441.80M | 2.47% | 1,272,723 | 92.62M |
| 232 | ANL | Adlai Nortye Ltd. | 440.00M | -2.31% | 98,035 | 5.00M |
| 233 | SGMT | Sagimet Biosciences Inc. | 435.97M | 2.92% | 397,356 | - |
| 234 | NGNE | Neurogene Inc. | 434.24M | 4.81% | 46,191 | 925.00K |
| 235 | VTVT | vTv Therapeutics Inc. | 430.86M | 5.40% | 35,576 | 36.84M |
| 236 | EPRX | Eupraxia Pharmaceuticals Inc. | 424.34M | 1.90% | 352,311 | - |
| 237 | PRLD | Prelude Therapeutics Incorporated | 405.64M | 11.75% | 399,890 | 16.72M |
| 238 | FBRX | Forte Biosciences, Inc. | 405.63M | -2.35% | 272,963 | - |
| 239 | UPB | Upstream Bio, Inc. | 404.34M | -2.62% | 688,230 | 3.32M |
| 240 | CNXU | Conexeu Sciences Inc. | 404.32M | -5.04% | 76,831 | - |
| 241 | MNPR | Monopar Therapeutics Inc. | 399.31M | -1.57% | 199,720 | - |
| 242 | IPSC | Century Therapeutics, Inc. | 396.78M | 6.28% | 512,701 | 109.16M |
| 243 | OABI | OmniAb, Inc. | 385.63M | 6.40% | 349,005 | 28.94M |
| 244 | CMPX | Compass Therapeutics, Inc. | 383.59M | 1.43% | 4,477,693 | 850.00K |
| 245 | BNTC | Benitec Biopharma Inc. | 379.62M | 6.25% | 44,936 | - |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 378.22M | 1.01% | 276,972 | 9.01M |
| 247 | VNDA | Vanda Pharmaceuticals Inc. | 375.85M | 2.63% | 671,470 | 217.78M |
| 248 | LXEO | Lexeo Therapeutics, Inc. | 375.33M | 6.22% | 533,991 | - |
| 249 | ARTV | Artiva Biotherapeutics, Inc. | 373.16M | 10.19% | 312,509 | 251.00K |
| 250 | STTK | Shattuck Labs, Inc. | 368.07M | 1.05% | 360,842 | 1.00M |
| 251 | PBYI | Puma Biotechnology, Inc. | 356.81M | 2.94% | 178,385 | 227.18M |
| 252 | RGNX | REGENXBIO Inc. | 355.68M | 2.84% | 1,250,735 | 87.82M |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 353.72M | 4.99% | 190,306 | - |
| 254 | ZURA | Zura Bio Limited | 348.21M | -4.92% | 1,544,762 | - |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 347.43M | -2.55% | 271,784 | - |
| 256 | LRMR | Larimar Therapeutics, Inc. | 343.42M | 2.81% | 1,693,077 | - |
| 257 | ENTA | Enanta Pharmaceuticals, Inc. | 342.83M | 4.89% | 208,575 | 69.21M |
| 258 | VSTM | Verastem, Inc. | 339.19M | 6.63% | 3,539,264 | 49.59M |
| 259 | NAUT | Nautilus Biotechnology, Inc. | 338.67M | 3.29% | 300,368 | - |
| 260 | ABEO | Abeona Therapeutics Inc. | 331.71M | 2.65% | 693,383 | 14.54M |
| 261 | IRD | Opus Genetics, Inc. | 331.31M | 10.48% | 1,086,641 | 11.98M |
| 262 | HUMA | Humacyte, Inc. | 330.81M | 6.43% | 6,311,800 | 2.02M |
| 263 | IVVD | Invivyd, Inc. | 327.01M | 0.91% | 3,755,053 | 55.87M |
| 264 | SLN | Silence Therapeutics plc | 323.56M | 6.86% | 197,267 | 839.00K |
| 265 | PALI | Palisade Bio, Inc. | 323.13M | - | 1,526,639 | - |
| 266 | NMRA | Neumora Therapeutics, Inc. | 319.70M | 0.57% | 704,177 | - |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 318.85M | - | 2,415,512 | - |
| 268 | FENC | Fennec Pharmaceuticals Inc. | 318.19M | 0.22% | 183,865 | 51.00M |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 314.68M | 3.36% | 93,424 | - |
| 270 | LYEL | Lyell Immunopharma, Inc. | 304.51M | 3.82% | 127,425 | 31.00K |
| 271 | LCTX | Lineage Cell Therapeutics, Inc. | 301.65M | 0.83% | 691,128 | 14.78M |
| 272 | BCYC | Bicycle Therapeutics plc | 298.09M | 1.67% | 209,951 | 63.50M |
| 273 | IFRX | InflaRx N.V. | 294.59M | -2.91% | 1,271,957 | 33.82K |
| 274 | IMRX | Immuneering Corporation | 289.84M | -1.54% | 1,064,032 | - |
| 275 | SRZN | Surrozen, Inc. | 283.06M | -0.77% | 77,259 | 7.49M |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 282.90M | -0.60% | 437,205 | 1.00 |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 282.19M | 1.32% | 31,320 | 5.20M |
| 278 | NAGE | Niagen Bioscience, Inc. | 279.34M | 1.74% | 580,813 | 130.42M |
| 279 | ELDN | Eledon Pharmaceuticals, Inc. | 278.29M | 3.15% | 616,811 | - |
| 280 | ZNTL | Zentalis Pharmaceuticals, Inc. | 275.49M | 4.03% | 566,953 | 26.87M |
| 281 | MGNX | MacroGenics, Inc. | 270.13M | 1.19% | 463,840 | 157.08M |
| 282 | AVXL | Anavex Life Sciences Corp. | 261.33M | 6.62% | 935,674 | - |
| 283 | FATE | Fate Therapeutics, Inc. | 257.60M | -0.45% | 3,588,034 | 6.32M |
| 284 | NVCT | Nuvectis Pharma, Inc. | 256.50M | 3.87% | 38,100 | - |
| 285 | ELTX | Elicio Therapeutics, Inc. | 256.26M | 11.17% | 294,067 | - |
| 286 | CDXS | Codexis, Inc. | 254.51M | 2.94% | 1,155,015 | 78.09M |
| 287 | TRDA | Entrada Therapeutics, Inc. | 252.23M | 6.38% | 235,390 | 5.74M |
| 288 | TARA | Protara Therapeutics, Inc. | 247.86M | 4.50% | 377,628 | - |
| 289 | SABS | SAB Biotherapeutics, Inc. | 243.86M | 3.27% | 303,981 | 114.70K |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 243.11M | 4.01% | 69,024 | 18.47M |
| 291 | CHRS | Coherus Oncology, Inc. | 242.94M | 7.14% | 839,730 | 46.88M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 238.92M | 3.37% | 152,747 | 32.72M |
| 293 | ACIU | AC Immune SA | 238.08M | 0.42% | 218,565 | 4.62M |
| 294 | QTTB | Q32 Bio Inc. | 237.39M | 14.85% | 1,054,199 | 53.74M |
| 295 | ADAG | Adagene Inc. | 235.22M | 2.89% | 254,201 | 7.67M |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 228.52M | 5.79% | 642,990 | 54.71M |
| 297 | CLLS | Cellectis S.A. | 227.37M | 1.94% | 101,950 | 75.11M |
| 298 | LENZ | LENZ Therapeutics, Inc. | 225.75M | 2.71% | 367,901 | 20.99M |
| 299 | FULC | Fulcrum Therapeutics, Inc. | 224.55M | 4.66% | 4,588,489 | 80.00M |
| 300 | CAMP | Camp4 Therapeutics Corporation | 223.28M | 3.12% | 61,915 | 3.93M |
| 301 | NERV | Minerva Neurosciences, Inc. | 222.69M | 2.14% | 57,418 | - |
| 302 | HELP | Cybin Inc. | 221.66M | 3.02% | 503,910 | - |
| 303 | YDES | YD Bio Limited | 221.16M | -12.88% | 12,048 | 510.36K |
| 304 | FHTX | Foghorn Therapeutics Inc. | 219.59M | 2.75% | 135,964 | 28.22M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 218.73M | 0.56% | 569,747 | 36.49M |
| 306 | WHWK | Whitehawk Therapeutics, Inc. | 218.47M | 1.84% | 196,170 | 7.15M |
| 307 | NGEN | NervGen Pharma Corp. | 213.47M | 5.24% | 1,209,819 | - |
| 308 | KROS | Keros Therapeutics, Inc. | 213.16M | 2.57% | 155,863 | 33.18M |
| 309 | RNA | Atrium Therapeutics, Inc. | 210.40M | 1.07% | 126,026 | 36.68M |
| 310 | CGEN | Compugen Ltd. | 209.98M | 1.37% | 566,942 | 72.66M |
| 311 | ALXO | ALX Oncology Holdings Inc. | 209.91M | -6.59% | 2,801,861 | - |
| 312 | NBP | NovaBridge Biosciences | 208.17M | 2.86% | 263,662 | - |
| 313 | CRBU | Caribou Biosciences, Inc. | 204.81M | 3.25% | 1,745,525 | 11.20M |
| 314 | KPTI | Karyopharm Therapeutics Inc. | 204.54M | 0.78% | 219,107 | 151.12M |
| 315 | ALEC | Alector, Inc. | 200.96M | 1.97% | 449,391 | 18.42M |
| 316 | EQ | Equillium, Inc. | 200.43M | 1.93% | 1,847,874 | 4.39M |
| 317 | UNCY | Unicycive Therapeutics, Inc. | 198.38M | 3.19% | 645,585 | - |
| 318 | NKTX | Nkarta, Inc. | 198.18M | 1.84% | 372,173 | - |
| 319 | IMUX | Immunic, Inc. | 196.56M | 1.83% | 207,296 | - |
| 320 | RNAC | Cartesian Therapeutics, Inc. | 192.45M | 4.55% | 87,513 | 1.78M |
| 321 | ENLV | Enlivex Ltd. | 190.55M | -7.00% | 383,427 | - |
| 322 | TNXP | Tonix Pharmaceuticals Holding Corp. | 189.38M | 4.21% | 582,231 | 17.56M |
| 323 | CNTX | Context Therapeutics Inc. | 186.51M | -0.98% | 564,766 | - |
| 324 | MDWD | MediWound Ltd. | 185.72M | 5.24% | 86,062 | 14.48M |
| 325 | MIST | Milestone Pharmaceuticals Inc. | 175.50M | 0.78% | 844,180 | 1.78M |
| 326 | OKUR | OnKure Therapeutics, Inc. | 173.70M | 2.38% | 1,949,482 | - |
| 327 | SPRO | Spero Therapeutics, Inc. | 172.55M | 6.43% | 1,022,454 | 61.19M |
| 328 | TTRX | Turn Therapeutics Inc. | 171.13M | -4.57% | 48,226 | - |
| 329 | IPHA | Innate Pharma S.A. | 169.51M | 2.27% | 8,171 | 10.57M |
| 330 | ADCT | ADC Therapeutics SA | 167.89M | -57.14% | 12,623,008 | 79.18M |
| 331 | TNYA | Tenaya Therapeutics, Inc. | 167.54M | -1.74% | 2,244,737 | 225.00K |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 165.40M | - | 334,590 | - |
| 333 | DTIL | Precision BioSciences, Inc. | 165.39M | 6.13% | 196,597 | 45.07M |
| 334 | TLSA | Tiziana Life Sciences Ltd | 164.22M | 7.63% | 196,699 | - |
| 335 | PLX | Protalix BioTherapeutics, Inc. | 161.95M | 2.55% | 572,270 | 76.38M |
| 336 | PRQR | ProQR Therapeutics N.V. | 161.20M | 4.08% | 545,368 | 15.73M |
| 337 | KRRO | Korro Bio, Inc. | 160.81M | 0.63% | 101,415 | 3.84M |
| 338 | GALT | Galectin Therapeutics Inc. | 156.74M | 1.28% | 111,429 | - |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 155.93M | 4.38% | 167,000 | 2.00M |
| 340 | MENS | Jyong Biotech Ltd. | 155.89M | 0.48% | 50,032 | - |
| 341 | ANTX | AN2 Therapeutics, Inc. | 150.10M | -0.71% | 169,775 | - |
| 342 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 148.41M | 8.54% | 829,783 | - |
| 343 | NRXP | NRx Pharmaceuticals, Inc. | 146.59M | - | 1,399,365 | 2.29M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 144.82M | 3.14% | 346,198 | 233.00K |
| 345 | MOLN | Molecular Partners AG | 144.58M | -2.48% | 2,325 | 856.30K |
| 346 | SPRB | Spruce Biosciences, Inc. | 143.68M | 8.40% | 67,350 | 697.00K |
| 347 | AGEN | Agenus Inc. | 141.02M | 5.43% | 514,642 | 123.87M |
| 348 | HURA | TuHURA Biosciences, Inc. | 139.46M | 3.30% | 296,487 | - |
| 349 | CNTN | Canton Strategic Holdings, Inc. | 138.81M | - | 638,669 | - |
| 350 | GNLX | Genelux Corporation | 136.78M | 2.67% | 138,636 | 8.00K |
| 351 | KZIA | Kazia Therapeutics Limited | 130.27M | 4.11% | 163,978 | 1.27M |
| 352 | ACOG | Alpha Cognition Inc. | 129.12M | -2.47% | 19,052 | 10.83M |
| 353 | CGTX | Cognition Therapeutics, Inc. | 121.52M | -4.23% | 1,808,404 | - |
| 354 | PLYX | Polaryx Therapeutics, Inc. | 119.78M | 0.40% | 257,168 | - |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 119.76M | -0.48% | 595,649 | 70.00M |
| 356 | ALPS | Alps Group Inc | 116.53M | -1.35% | 21,118 | 3.74M |
| 357 | GUTS | Fractyl Health, Inc. | 116.38M | -3.47% | 2,122,631 | 3.00K |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 115.57M | 4.94% | 35,446 | 39.99K |
| 359 | ENGN | enGene Therapeutics Inc. | 115.22M | 2.99% | 644,759 | - |
| 360 | COYA | Coya Therapeutics, Inc. | 114.24M | 4.96% | 156,084 | 7.94M |
| 361 | VANI | Vivani Medical, Inc. | 110.38M | - | 102,613 | - |
| 362 | PYXS | Pyxis Oncology, Inc. | 108.34M | 0.59% | 284,043 | 13.86M |
| 363 | KLRS | Kalaris Therapeutics, Inc. | 107.14M | -1.27% | 39,549 | - |
| 364 | CBUS | Cibus, Inc. | 106.80M | 0.72% | 127,316 | 3.64M |
| 365 | ALDX | Aldeyra Therapeutics, Inc. | 106.17M | -5.38% | 1,062,005 | - |
| 366 | CRDF | Cardiff Oncology, Inc. | 105.97M | 10.71% | 1,722,300 | 525.00K |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 105.65M | 4.77% | 42,975 | 37.16M |
| 368 | SEER | Seer, Inc. | 104.38M | -0.54% | 45,124 | 16.58M |
| 369 | PEPG | PepGen Inc. | 102.37M | 4.23% | 478,006 | - |
| 370 | ONCY | Oncolytics Biotech Inc. | 100.68M | -1.48% | 1,017,346 | - |
| 371 | BMEA | Biomea Fusion, Inc. | 99.05M | 5.38% | 1,482,351 | - |
| 372 | CUE | Cue Biopharma, Inc. | 96.49M | 10.14% | 52,633 | 32.73M |
| 373 | OTLK | Outlook Therapeutics, Inc. | 96.06M | -1.85% | 10,688,755 | 333.14K |
| 374 | INO | Inovio Pharmaceuticals, Inc. | 95.05M | 1.75% | 1,275,341 | 65.34K |
| 375 | RNTX | Rein Therapeutics Inc. | 94.90M | - | 441,467 | - |
| 376 | PYPD | PolyPid Ltd. | 92.61M | 2.33% | 170,544 | - |
| 377 | FBIO | Fortress Biotech, Inc. | 92.02M | 6.13% | 424,728 | 66.16M |
| 378 | HYFT | MindWalk Holdings Corp. | 91.88M | 2.78% | 256,881 | 20.70M |
| 379 | HRTX | Heron Therapeutics, Inc. | 91.52M | 8.21% | 5,002,329 | 150.71M |
| 380 | MAIA | MAIA Biotechnology, Inc. | 91.20M | 4.90% | 3,311,815 | - |
| 381 | PTHS | Pelthos Therapeutics Inc. | 89.88M | -0.08% | 6,587 | 27.70M |
| 382 | RANI | Rani Therapeutics Holdings, Inc. | 89.69M | 2.69% | 710,297 | 3.17M |
| 383 | ICCC | ImmuCell Corporation | 89.65M | -1.39% | 8,708 | 29.93M |
| 384 | OKYO | OKYO Pharma Limited | 88.17M | 1.20% | 58,586 | - |
| 385 | ANIX | Anixa Biosciences, Inc. | 87.84M | 3.97% | 92,269 | - |
| 386 | ATRA | Atara Biotherapeutics, Inc. | 87.42M | 6.65% | 94,372 | 23.14M |
| 387 | PMN | ProMIS Neurosciences, Inc. | 87.26M | 0.83% | 14,363 | - |
| 388 | AARD | Aardvark Therapeutics, Inc. | 86.61M | 4.20% | 91,148 | - |
| 389 | RLYB | Rallybio Corporation | 85.69M | 0.81% | 33,805 | 858.00K |
| 390 | ACET | Adicet Bio, Inc. | 85.16M | 3.58% | 63,316 | - |
| 391 | ANVS | Annovis Bio, Inc. | 84.66M | 7.57% | 2,035,183 | - |
| 392 | NRXS | NeurAxis, Inc. | 83.64M | 2.83% | 95,487 | 4.28M |
| 393 | OSTX | OS Therapies Incorporated | 82.40M | 2.78% | 380,671 | - |
| 394 | LIXT | Lixte Biotechnology Holdings, Inc. | 81.33M | 4.32% | 183,321 | - |
| 395 | LONA | LeonaBio, Inc. | 80.88M | -0.23% | 18,484 | - |
| 396 | CSBR | Champions Oncology, Inc. | 79.99M | 1.23% | 1,489 | 57.95M |
| 397 | GANX | Gain Therapeutics, Inc. | 79.34M | 3.91% | 369,387 | - |
| 398 | EXOZ | eXoZymes, Inc. | 79.28M | -1.16% | 7,287 | -700.00 |
| 399 | XBIT | XBiotech Inc. | 72.87M | - | 24,282 | - |
| 400 | PLRX | Pliant Therapeutics, Inc. | 72.45M | -0.85% | 321,079 | - |
| 401 | BYSI | BeyondSpring Inc. | 70.73M | -1.15% | 14,658 | 1.88M |
| 402 | ATHE | Alterity Therapeutics Limited | 70.35M | -2.74% | 24,066 | 4.43M |
| 403 | IBIO | iBio, Inc. | 69.76M | 4.89% | 854,790 | 300.00K |
| 404 | PDSB | PDS Biotechnology Corporation | 68.10M | 12.96% | 1,123,060 | - |
| 405 | VERU | Veru Inc. | 67.89M | 88.00% | 92,741,135 | 16.89M |
| 406 | FLNA | Filana Therapeutics, Inc. | 67.63M | 2.94% | 198,538 | - |
| 407 | TCRX | TScan Therapeutics, Inc. | 66.66M | 4.94% | 406,761 | 9.14M |
| 408 | ACRV | Acrivon Therapeutics, Inc. | 66.34M | 2.65% | 258,872 | - |
| 409 | MCRB | Seres Therapeutics, Inc. | 66.33M | -4.46% | 132,712 | 1.15M |
| 410 | MNOV | MediciNova, Inc. | 64.97M | - | 8,768 | 596.64K |
| 411 | IMA | ImageneBio, Inc. | 64.18M | 4.40% | 5,282 | 800.00K |
| 412 | CING | Cingulate Inc. | 63.72M | -1.64% | 611,083 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 63.52M | -0.08% | 36,412 | - |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 63.46M | 2.59% | 114,917 | - |
| 415 | EDSA | Edesa Biotech, Inc. | 63.00M | 3.35% | 145,298 | - |
| 416 | IBO | Impact BioMedical Inc. | 60.85M | 4.15% | 64,003 | 39.00K |
| 417 | ENTX | Entera Bio Ltd. | 60.05M | - | 53,279 | 42.00K |
| 418 | DWTX | Dogwood Therapeutics, Inc. | 56.11M | 4.35% | 27,183 | - |
| 419 | TIL | Instil Bio, Inc. | 55.21M | -1.09% | 10,243 | - |
| 420 | IMMP | Immutep Limited | 52.61M | -4.45% | 793,427 | 5.28M |
| 421 | MREO | Mereo BioPharma Group plc | 50.76M | -4.85% | 3,038,395 | 500.00K |
| 422 | ATYR | aTyr Pharma, Inc. | 50.30M | 2.58% | 1,407,685 | 190.00K |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 50.07M | - | 119,027 | 22.33M |
| 424 | HYPD | Hyperion DeFi, Inc. | 49.72M | -3.05% | 256,044 | 1.04M |
| 425 | XLO | Xilio Therapeutics, Inc. | 49.72M | 2.03% | 8,219 | 53.48M |
| 426 | ESLA | Estrella Immunopharma, Inc. | 49.49M | 10.58% | 177,932 | - |
| 427 | LTRN | Lantern Pharma Inc. | 48.17M | 11.47% | 340,981 | - |
| 428 | RADX | Radiopharm Theranostics Limited | 48.09M | 3.12% | 27,186 | 10.86M |
| 429 | ACTU | Actuate Therapeutics, Inc. | 46.42M | 6.59% | 59,538 | - |
| 430 | GNTA | Genenta Science S.p.A. | 46.24M | -7.11% | 933,659 | - |
| 431 | RNXT | RenovoRx, Inc. | 43.94M | 7.71% | 524,251 | 1.49M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | 3.25% | 34,984 | - |
| 433 | NTRB | Nutriband Inc. | 43.52M | 1.99% | 10,603 | 2.04M |
| 434 | GOSS | Gossamer Bio, Inc. | 41.73M | -5.58% | 8,994,493 | 55.54M |
| 435 | TVGN | Tevogen Bio Holdings Inc. | 41.67M | 9.82% | 16,443 | - |
| 436 | KALA | KALA BIO, Inc. | 41.46M | -0.45% | 99,950 | - |
| 437 | ATOS | Atossa Therapeutics, Inc. | 40.99M | 1.28% | 46,767 | - |
| 438 | GRDX | GridAI Technologies Corp. | 40.32M | 2.19% | 33,664 | - |
| 439 | PSTV | Plus Therapeutics, Inc. | 39.42M | 6.00% | 102,592 | 5.21M |
| 440 | GRCE | Grace Therapeutics, Inc. | 36.98M | -2.45% | 360,781 | - |
| 441 | ABVC | ABVC BioPharma, Inc. | 36.39M | 12.50% | 192,269 | 797.92K |
| 442 | INMB | INmune Bio Inc. | 35.89M | 2.27% | 312,600 | 50.00K |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 34.61M | -4.31% | 288,840 | 90.00K |
| 444 | NNVC | NanoViricides, Inc. | 34.17M | -0.66% | 234,763 | - |
| 445 | ALGS | Aligos Therapeutics, Inc. | 33.05M | 3.89% | 169,131 | 4.71M |
| 446 | BOLD | Boundless Bio, Inc. | 32.95M | 2.08% | 72,155 | - |
| 447 | DARE | Daré Bioscience, Inc. | 32.66M | 6.34% | 170,801 | 1.16M |
| 448 | EVAX | Evaxion A/S | 32.28M | 9.32% | 57,466 | 7.53M |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 31.14M | 2.53% | 132,471 | 38.00K |
| 450 | APLM | Apollomics, Inc. | 30.74M | 0.57% | 6,044 | 8.84M |
| 451 | LSTA | Lisata Therapeutics, Inc. | 30.44M | -3.16% | 95,764 | 170.00K |
| 452 | QNTM | Quantum BioPharma Ltd. | 30.42M | -8.20% | 583,055 | - |
| 453 | LITS | Lite Strategy, Inc. | 29.40M | -0.55% | 895,237 | - |
| 454 | IGC | IGC Pharma, Inc. | 28.92M | -2.43% | 466,468 | 1.11M |
| 455 | CRVO | CervoMed Inc. | 28.89M | 5.05% | 45,274 | 2.09M |
| 456 | CELU | Celularity Inc. | 28.86M | -2.24% | 192,329 | 26.55M |
| 457 | BCTX | BriaCell Therapeutics Corp. | 28.70M | -1.51% | 102,428 | - |
| 458 | TVRD | Tvardi Therapeutics, Inc. | 28.61M | 3.39% | 33,383 | - |
| 459 | BRNS | Barinthus Biotherapeutics plc | 28.19M | -1.53% | 493 | 14.97M |
| 460 | SER | Serina Therapeutics, Inc. | 27.71M | 3.91% | 147,025 | 130.00K |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 27.58M | -0.04% | 163,958 | - |
| 462 | KYNB | Kyntra Bio, Inc. | 27.57M | - | 3,840 | 7.44M |
| 463 | SKYE | Skye Bioscience, Inc. | 27.22M | 0.61% | 295,554 | - |
| 464 | DYAI | Dyadic International, Inc. | 26.36M | 3.20% | 70,961 | 3.81M |
| 465 | ALLR | Allarity Therapeutics, Inc. | 26.28M | 7.59% | 210,546 | 345.00K |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 26.16M | 2.98% | 129,464 | -13.27K |
| 467 | PLUR | Pluri Inc. | 25.68M | 0.85% | 11,619 | 1.08M |
| 468 | PTN | Palatin Technologies, Inc. | 24.87M | 6.22% | 12,261 | 12.88M |
| 469 | MRKR | Marker Therapeutics, Inc. | 24.68M | 2.07% | 65,844 | 3.55M |
| 470 | PLRZ | Polyrizon Ltd. | 23.96M | -4.90% | 26,407 | - |
| 471 | LGVN | Longeveron Inc. | 23.42M | - | 175,192 | 1.22M |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 22.81M | 2.77% | 292,641 | 789.00K |
| 473 | TRAW | Traws Pharma, Inc. | 22.42M | 2.07% | 135,316 | 2.73M |
| 474 | SNSE | Sensei Biotherapeutics, Inc. | 22.28M | 4.76% | 36,794 | - |
| 475 | CVM | CEL-SCI Corporation | 22.17M | 3.38% | 146,760 | - |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.16M | 1.39% | 47,266 | 454.00K |
| 477 | CLRB | Cellectar Biosciences, Inc. | 21.98M | 5.77% | 137,052 | - |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 20.90M | 1.78% | 193,578 | 1.14M |
| 479 | KTTA | Pasithea Therapeutics Corp. | 20.71M | -2.87% | 450,655 | - |
| 480 | CRIS | Curis, Inc. | 19.99M | - | 62,697 | 7.06M |
| 481 | AEON | AEON Biopharma, Inc. | 19.40M | 0.79% | 16,602 | - |
| 482 | PASG | Passage Bio, Inc. | 19.25M | 0.50% | 49,353 | - |
| 483 | XCUR | Exicure, Inc. | 18.87M | -6.33% | 22,114 | 500.00K |
| 484 | TPST | Tempest Therapeutics, Inc. | 18.65M | 2.36% | 105,157 | - |
| 485 | AKTX | Akari Therapeutics, Plc | 18.13M | 5.71% | 69,079 | - |
| 486 | QNCX | Quince Therapeutics, Inc. | 17.93M | 6.80% | 1,033,737 | - |
| 487 | LPCN | Lipocine Inc. | 17.74M | 0.91% | 73,682 | 2.00M |
| 488 | GTBP | GT Biopharma, Inc. | 17.20M | 8.58% | 1,626,833 | - |
| 489 | NCEL | NewcelX Ltd. | 16.96M | -0.32% | 22,759 | - |
| 490 | MLEC | Moolec Science SA | 16.73M | -0.74% | 128,602 | 7.83M |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 16.18M | 1.59% | 177,198 | 5.61M |
| 492 | HIND | Vyome Holdings, Inc. | 16.14M | 1.77% | 19,650 | 152.72K |
| 493 | LEXX | Lexaria Bioscience Corp. | 15.76M | 2.65% | 147,300 | 368.00K |
| 494 | INAB | IN8bio, Inc. | 15.16M | - | 37,900 | - |
| 495 | OSRH | OSR Holdings, Inc. | 14.60M | -1.12% | 863,928 | 2.63M |
| 496 | COCP | Cocrystal Pharma, Inc. | 14.48M | -0.94% | 200,811 | 225.00K |
| 497 | GDTC | CytoMed Therapeutics Limited | 13.96M | - | 3,688 | 669.28K |
| 498 | BLRX | BioLineRx Ltd. | 13.61M | -1.22% | 20,921 | 1.40M |
| 499 | JSPR | Jasper Therapeutics, Inc. | 13.47M | -9.58% | 864,942 | - |
| 500 | MBRX | Moleculin Biotech, Inc. | 13.39M | 2.03% | 263,690 | - |